12:00 AM
 | 
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Other News

Ark Therapeutics, Crawford Healthcare Holdings Ltd. cancer, cardiovascular, gene/cell therapy news

Crawford's Crawford Woundcare Ltd. subsidiary will acquire Ark Therapeutics' Patient Plus Ltd. wound care business and certain associated IP for £765,000 ($1.2 million) up front in cash and up to £1.9 million ($3.1 million) in milestones. Ark said it...

Read the full 175 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >